Ravulizumab (Anti-Complement C5)
Product Specifications
CAS Number
1803171-55-2
Synonyms
ALXN1210
Additionnal Information
Ravulizumab (Anti-Complement C5) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A02885-1-Dylight550 100 µg
Anti-ATG4B Antibody Picoband®, Dylight550 Conjugate
Sign In for Pricing
View Details 
302718-ML405 100 µL
Rps6ka5 (Ribosomal Protein S6 Kinase alpha-5, S6K-alpha-5, 90kD Ribosomal Protein S6 Kinase 5, Nuclear Mitogen- and Stress-Activated Protein Kinase 1, RSK-like Protein Kinase, RLSK, Rps6ka5, Msk1) (MaxLight 405) discontinued
Sign In for Pricing
View Details